Introduction of the Pharmaceutical Contract Development and Manufacturing Market Report

A contract manufacturing organization also called contract development and organization, is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing.

To have an edge over the competition by knowing the market dynamics and current trends of “Pharmaceutical Contract Development and Manufacturing Market”, request for Sample Report here

Market Dynamic

Key Drivers and Emerging Trends

The rising demand for manufacturing expertise is gaining popularity globally, which the FDA highly promotes along with the US center for drug evaluation and research, driving the funding and share of the market. In addition, due to economic miseries globally, numerous countries are seeking ways to curtail drug expenditures. Pharma and biotech companies have been charged with the difficult task of minimizing drug costs, which in turn has led them to assess prospects for manufacturing outsourcing. Asian CMOs are making ventures into the innovation and expansion market by acquiring assets in Europe and the United States. Furthermore, CMOs are strengthening for expanding productivity in the competitive market. Through amalgamation, the large CMOs can expand their regional presence and enter niche markets. For instance, in 2019, SK Holdings, the holding company of South Korea’s SK Group, established a US-based contract manufacturing organization (CMO), SK pharmteco, a collaboration between SK biotek in Korea and AMPAC Fine Chemicals (AFC) in the United States, which has helped the market. According to the Association for Accessible Medicines, the US healthcare system saved USD 313 billion in 2019 alone. In the same year, Medicare and Medicaid saved USD 96 billion and USD 48.5 billion, respectively. Considering such cost benefits, governments across countries are promoting the use of generic drugs.

Restraint in the Pharmaceutical Contract Development and Manufacturing Market

However, stringent government regulations in the manufacturing of API and drugs is the major factor which is likely to hamper the growth of the market.

Do you want to know more about the Research process and detailed Methodology, Request Research Methodology of this report

Service – Segment Analysis

Based on the service, pharmaceutical manufacturing services is witnessed to grow at a higher CAGR in the market over the forecast period. This is due to the high demand and consumption of generic drugs and liquid dosage forms, which has led to the expansion of the market. In addition, it also offers the advantages like, it is cost effective, advanced skills, quality assurance, which has led to the better efficiency and expansion of the sector.

End-User – Segment Analysis

Based on the end-user, big pharmaceutical companies are witnessed to grow at a higher CAGR in the market over the forecast period. This is due to the rising number of mergers and acquisitions in the pharmaceutical sector, which has helped in changing the landscape of the market. For instance, acquisitions by the key players in the market for example, in 2019 Catalent acquired Paragon Bio services, in 2017 Thermofisher Scientific acquitted Patheon’s, etc. which has driven the market.

In case, any of your pain points areas are not covered in the current scope of this report, Request for Free Customization here

Regional – Segment Analysis:

Based on the regional coverage Asia-Pacific is expected to grow at a higher CAGR in the market over the forecast period. This is due to the strategic initiatives by the countries like India, China, and Japan, which have helped in the regional expansion of the market. For instance, “Ministry of Health and Family Welfare India”, has announced US$ 9.30 billion under the 2020-2021 budget which has shifted the paddles for the market in the Asia-Pacific.

Top Market Players

Various notable players operating in the market, include, Boehringer Ingelheim GmbH, Lonza, Grifols S.A, Jubilant Life Sciences Limited, Pfizer, Inc. (Pfizer CenterOne), Charles River Laboratories International, Inc., Albany Molecular Research, Inc., Covance, Inc. (LabCorp), QuintilesIMS, Baxter BioPharma Solutions, among others. 

Key Developments:

• • In 2021, Lonza entered into an agreement with Aruvant Science, for sickle-cell treatment in the US, leading to the expansion of both the companies.

Segments covered in the Report:

The global Pharmaceutical Contract Development and Manufacturing market has been segmented on the basis of service, end-user, and regions. Based on service, the market is segmented into pharmaceutical manufacturing sevices, drug development services and biologics manufacturing devices. Based on end-user, the market is segmented into big pharmaceutical companies, small & medium sized pharmaceutical companies, generic pharmaceutical companies, and others. 

For detailed scope of the “Pharmaceutical Contract Development and Manufacturing Market” report request a Sample Copy of the report

Key questions answered in this research report:

• • At what pace is global Pharmaceutical Contract Development and Manufacturing market growing? What will be the growth trend in the future?
  • What are the key drivers and restraints in Pharmaceutical Contract Development and Manufacturing market? What will be the impact of drivers and restraints in the future?
  • What are the regional revenues and forecast breakdowns? Which are the major regional revenue pockets for growth in the global Pharmaceutical Contract Development and Manufacturing market?
  • Which service generated maximum revenues in 2020 and identify the most promising service during the forecast period?
  • What are the various end-user areas of global Pharmaceutical Contract Development and Manufacturing market and how they are poised to grow?
  • What companies are the major participants in this market and their business strategies, how does the competitive landscape look like?

Report Coverage	Details
Market Base Year	2020
Market Forecast Period	2021-2028
Market Revenues Currency	USD Million
Base Year & Forecast Units	Revenues (USD Million)
Market Segment	By Service, By End-User, By Region
Regional Coverage	Asia Pacific, Europe, North America, and RoW
Companies Profiled	Boehringer Ingelheim GmbH, Lonza, Grifols S.A, Jubilant Life Sciences Limited, Pfizer, Inc. (Pfizer CenterOne), Charles River Laboratories International, Inc., Albany Molecular Research, Inc., Covance, Inc. (LabCorp), QuintilesIMS, Baxter BioPharma Solutions, among others; a total of 10 companies covered.
25% Free Customization Available	We will customize this report up to 25% as a free customization to address our client’s specific requirements

Market Segmentation

Global Pharmaceutical Contract Development and Manufacturing Market by Service

• • Pharmaceutical Manufacturing Devices
  • Drug Development Services
  • Biologics Manufacturing Devices

Global Pharmaceutical Contract Development and Manufacturing Market by End-User

• • Big Pharmaceutical Companies
  • Small & Medium Sized Pharmaceutical Companies
  • Generic Pharmaceutical Companies
  • Others

Global Pharmaceutical Contract Development and Manufacturing Market by Region

• • North America Pharmaceutical Contract Development and Manufacturing Market (Option 1: As a part of the free 25% customization)
    • North America Pharmaceutical Contract Development and Manufacturing Market by Service
    • North America Pharmaceutical Contract Development and Manufacturing Market by End-User
    • US Pharmaceutical Contract Development and Manufacturing Market All-Up
    • Canada Pharmaceutical Contract Development and Manufacturing Market All-Up
  • Europe Pharmaceutical Contract Development and Manufacturing Market (Option 2: As a part of the free 25% customization)
    • Europe Pharmaceutical Contract Development and Manufacturing Market by Service
    • Europe Pharmaceutical Contract Development and Manufacturing Market by End-User
    • UK Pharmaceutical Contract Development and Manufacturing Market All-Up
    • Germany Pharmaceutical Contract Development and Manufacturing Market All-Up
    • France Pharmaceutical Contract Development and Manufacturing Market All-Up
    • Spain Pharmaceutical Contract Development and Manufacturing Market All-Up
    • Rest of Europe Pharmaceutical Contract Development and Manufacturing Market All-Up
  • Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market (Option 3: As a part of the free 25% customization)
    • Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market by Service
    • Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market by End-User
    • China Pharmaceutical Contract Development and Manufacturing Market All-Up
    • India Pharmaceutical Contract Development and Manufacturing Market All-Up
    • Japan Pharmaceutical Contract Development and Manufacturing Market All-Up
    • Rest of APAC Pharmaceutical Contract Development and Manufacturing Market All-Up
  • RoW Pharmaceutical Contract Development and Manufacturing Market (Option 4: As a part of the free 25% customization)
    • RoW Pharmaceutical Contract Development and Manufacturing Market by Service
    • RoW Pharmaceutical Contract Development and Manufacturing Market by End-User
    • Brazil Pharmaceutical Contract Development and Manufacturing Market All-Up
    • South Africa Pharmaceutical Contract Development and Manufacturing Market All-Up
    • Saudi Arabia Pharmaceutical Contract Development and Manufacturing Market All-Up
    • UAE Pharmaceutical Contract Development and Manufacturing Market All-Up
    • Rest of world (remaining countries of the LAMEA region) Pharmaceutical Contract Development and Manufacturing Market All-Up

Major Players Operating in the Pharmaceutical Contract Development and Manufacturing (Option 5: As a part of the Free 25% Customization – Profiles of 5 Additional Companies of your Choice)

• • Boehringer Ingelheim GmbH
  • Lonza
  • Grifols S.A
  • Jubilant Life Sciences Limited
  • Pfizer, Inc. (Pfizer CenterOne)
  • Charles River Laboratories International, Inc.
  • Albany Molecular Research, Inc.
  • Covance, Inc. (LabCorp)
  • QuintilesIMS
  • Baxter BioPharma Solutions